首页> 外国专利> THE USE OF CD40:CD154 BINDING INTERRUPTER TO PREVENT COUNTERADAPTIVE IMMUNE RESPONSES, PARTICULARLYNT COUNTERADAPTIVE IMMUNE RESPONSES, PARTICULARLY GRAFT REJECTION GRAFT REJECTION

THE USE OF CD40:CD154 BINDING INTERRUPTER TO PREVENT COUNTERADAPTIVE IMMUNE RESPONSES, PARTICULARLYNT COUNTERADAPTIVE IMMUNE RESPONSES, PARTICULARLY GRAFT REJECTION GRAFT REJECTION

机译:使用CD40:CD154结合干扰物预防反适应性免疫反应,尤其是反适应性免疫反应,尤其是移植物排斥移植物排斥

摘要

The compositions and the methods are used for extending the survival of the graft tissue in a host recepient in order to avoid any acute rejection of the graft and reduce the immunologocal consequences of the failure of the graft. The rejection of a tissue graft can be inhibited by using CD40:CD154 interupter of binding be it individual or in combination with another immunomodulator or immunosuppressor. The synergic combination includes CD40:CD154 interrupter of binding and CD28 interrupter of feeding the signal. An example for a CD40:CD154 connection interrupter is an anti-CD154 monoclonal antibody as an antibody having antigen-specific characteristics of binding of 5c8 monoclonal antibody. An example for CD28 interrupter of signalling is CTLA4-lg merged protein. 51 claims
机译:所述组合物和方法用于延长宿主组织中移植组织的存活,以避免移植物的任何急性排斥并减少移植失败的免疫学后果。可以通过单独或与另一种免疫调节剂或免疫抑制剂组合使用CD40:CD154结合相互作用抑制剂来抑制组织移植物的排斥。协同组合包括结合的CD40:CD154阻断剂和馈入信号的CD28阻断剂。 CD40:CD154连接中断器的一个例子是抗CD154单克隆抗体,它是具有结合5c8单克隆抗体的抗原特异性特征的抗体。 CD28信号转导阻断剂的一个例子是CTLA4-Ig融合蛋白。 51个索赔

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号